GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vitrolife AB (FRA:VTFN) » Definitions » Gross Profit

Vitrolife AB (FRA:VTFN) Gross Profit : €183.2 Mil (TTM As of Sep. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Vitrolife AB Gross Profit?

Vitrolife AB's gross profit for the three months ended in Sep. 2024 was €44.7 Mil. Vitrolife AB's gross profit for the trailing twelve months (TTM) ended in Sep. 2024 was €183.2 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Vitrolife AB's gross profit for the three months ended in Sep. 2024 was €44.7 Mil. Vitrolife AB's Revenue for the three months ended in Sep. 2024 was €76.4 Mil. Therefore, Vitrolife AB's Gross Margin % for the quarter that ended in Sep. 2024 was 58.59%.

Vitrolife AB had a gross margin of 58.59% for the quarter that ended in Sep. 2024 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of Vitrolife AB was 68.39%. The lowest was 55.04%. And the median was 64.29%.

Warning Sign:

Vitrolife AB gross margin has been in long-term decline. The average rate of decline per year is -3.4%.


Vitrolife AB Gross Profit Historical Data

The historical data trend for Vitrolife AB's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vitrolife AB Gross Profit Chart

Vitrolife AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 89.56 75.45 101.84 161.91 176.74

Vitrolife AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 39.98 45.95 42.50 49.96 44.75

Competitive Comparison of Vitrolife AB's Gross Profit

For the Medical Devices subindustry, Vitrolife AB's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vitrolife AB's Gross Profit Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vitrolife AB's Gross Profit distribution charts can be found below:

* The bar in red indicates where Vitrolife AB's Gross Profit falls into.



Vitrolife AB Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Vitrolife AB's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=313.963 - 137.225
=176.7

Vitrolife AB's Gross Profit for the quarter that ended in Sep. 2024 is calculated as

Gross Profit (Q: Sep. 2024 )=Revenue - Cost of Goods Sold
=76.368 - 31.622
=44.7

Gross Profit for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €183.2 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Vitrolife AB's Gross Margin % for the quarter that ended in Sep. 2024 is calculated as

Gross Margin % (Q: Sep. 2024 )=Gross Profit (Q: Sep. 2024 ) / Revenue (Q: Sep. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=44.7 / 76.368
=58.59 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Vitrolife AB  (FRA:VTFN) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Vitrolife AB had a gross margin of 58.59% for the quarter that ended in Sep. 2024 => Durable competitive advantage


Vitrolife AB Gross Profit Related Terms

Thank you for viewing the detailed overview of Vitrolife AB's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Vitrolife AB Business Description

Traded in Other Exchanges
Address
Box 9080, Gothenburg, SWE, 400 92
Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient's fertility treatment, thereby enabling patients to receive support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction. The group has three geographical segments EMEA, Americas and APAC, out of which it derives maximum revenue from EMEA.

Vitrolife AB Headlines

No Headlines